期刊文献+

山楂叶总黄酮自微乳化释药系统的研究 被引量:8

Self-microemulsifying drug delivery system of flavonoids in hawthorn leaves
下载PDF
导出
摘要 目的研究山楂叶总黄酮自微乳化释药系统的处方工艺。方法通过溶解度、处方配伍试验和伪三元相图的绘制,以色泽、乳化时间和乳化后粒径大小为指标,筛选油相、表面活性剂、助表面活性剂的最佳配伍和处方配比。并以益心酮片为参比,测定山楂叶总黄酮自微乳化释药系统的溶出度。结果山楂叶的自微乳化处方中油相为乳化剂为Labrasol(35%),助乳化剂为Transcutol P(10%)。自微乳化后的粒径为(39.5±5.4)nm,自微乳化时间小于1min。蒸馏水中10min累积溶出度达70%以上,而益心酮片60min的溶出度不足50%。结论所制备的山楂叶总黄酮自微乳化释药系统达到了设计要求,为山楂叶总黄酮新制剂开发提供了依据。 Objective To develop the formulation of self-microemulsifying drug delivery system for hawthorn leaves flavonoids (HAW-SMEDDS). Methods The optimum formulations of oil phase, surfactant, and assistant surfactant for HAW-SMEDDS were screened by solubility test, compatibility test, and pseudo-ternary phase diagrams, with the time of formulating microemulsion, the consequence of visual examination, and particle size as indexes. The dissolution of HAW-SMEDDS was measured, taking the commercial tablet Yixintong Tablet as reference. Results The optimum self-microemulsifying drug delivery system was composed of Labrasol (35%), Transcutol P (10%). The particle diameter was (39.5±5.4) nm, the time of self-microemulsifying was less than 1 min. The percent of accumulated dissolution of hawthorn leaves flavonoids in SMEDDS in distilled water was up to 70% at 10 min, while that in the Yixintong Tablet was less than 50% at 60 min. Conclusion The formulation of HAW-SMEDDS preparation could meet the request of the design. It could provide the reference for the new dosage form.
机构地区 广东药学院
出处 《中草药》 CAS CSCD 北大核心 2008年第6期834-837,共4页 Chinese Traditional and Herbal Drugs
基金 广东省科技计划项目(2007B060401058)
关键词 山楂叶总黄酮 自微乳化释药系统 处方研究 flavonoids in hawthorn leaves self-microemulsifying drug delivery system (SMEDDS) formulation design
  • 相关文献

参考文献8

  • 1.中国药典[S]一部[M].,2005年版.6.
  • 2Khoo S M, Andrew J H. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine [J]. Int J Pharm, 1998, 167:155-164.
  • 3Itoh K, Tozuka Y, Oguchi T, et al. Improvement of physicochemical properties of N-4472 part I formulation design by using self-microemulsifying system [J]. Int J Pharm, 2002, 238..153-160.
  • 4Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs [J]. Eur J Pharm Biopharm, 2000, 50(1) :179-185.
  • 5Bachynsky M O, Shah N H, Paatel C I, et al. Factors affecting the efficiency of a self-emulsifying oral delivery system [J]. Drug Devel Ind Pharm, 1997, 23(8):809-814.
  • 6Shah N H, Carvajal M T, Patel C I, et al. Self-emulsifying drug delivery systems (SEDDS) with polyglycolzed gly cerides for improving in vitro dissolution and oral absorption of lipophilic drugs [J]. Int J Pharrn, 1994, 106(1):15-23.
  • 7Pouton C W. Self-emulsifying drug delivery systems : assessment of the efficiency of emulsification [J]. Int J Pharm, 1985, 27:335-342.
  • 8Kommuru T R, Gurley B, Khan M A, et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment [J]. Int J Pharm, 2001, 212(1):233-246.

共引文献860

同被引文献87

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部